GlassScriptPhysician profile
Arlene Palanca
NPI 1598436982
$2,196.24
in general payments reported to CMS, 2019-2025
16 companies · $525 in 2025
The $525 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $479 · 2023: $172 · 2024: $722 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $862.86 | 2021-2025 | Farxiga, Airsupra, Lokelma |
| Novo Nordisk INC | $656.30 | 2022-2025 | Ozempic, Rybelsus |
| Csl Behring | $163.28 | 2021 | |
| Lilly USA, LLC | $82.50 | 2021-2023 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $65.64 | 2024-2025 | Rexulti |
| Ucb, INC. | $64.54 | 2022 | |
| Alpha Cognition USA, INC. | $63.06 | 2025 | Zunveyl |
| Pfizer INC. | $48.34 | 2023-2025 | |
| Abbvie INC. | $43.10 | 2024-2025 | |
| Lundbeck LLC | $34.25 | 2024-2025 | Rexulti |
| Abiomed | $31.30 | 2025 | |
| Dexcom, INC. | $18.25 | 2024 | Dexcom G6 Transmitter |
| Acadia Pharmaceuticals INC | $16.01 | 2025 | Nuplazid |
| Bayer Healthcare Pharmaceuticals INC. | $16.01 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.94 | 2025 | Caplyta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $14.86 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Palanca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.